Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTH for Neuroprotection in Acute Optic Neuritis
NCT01838174Phase 4Terminated
- Sponsor
- University of Colorado Denver
- Start
- May 2013
- Primary completion
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in optic neuritis (ON), sponsored by University of Colorado Denver. Started May 2013; status: terminated.
02
Drugs
repository corticotropin injection
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT01838174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01838174.